36 results
Thumbnail

D3.121 - Evaluation of small airway dysfunction in severe asthma treated with anti-IgE and anti-eosinophilic therapies: A prospective comparative study

Thumbnail

D3.109 - Clinical Characteristics of Asthma Patients with Fungal Sensitization: A Retrospective Cross-Sectional Study

Thumbnail

D3.110 - Patterns of Opioid or Neuromodulator Use in Chronic Cough Patients with Newly Diagnosed Asthma

Thumbnail

D3.111 - The Impact of War on the Course of Asthma

Thumbnail

D3.112 - Clinical Characteristics and Evaluation of Serum Inflammatory Markers in Patients Hospitalized Due to Asthma Exacerbations

Thumbnail

D3.113 - The Diagnostic Value of Exercise Bronchial Provocation Testing in Pediatric Asthma

Thumbnail

D3.114 - Characterization on genome-wide profile of H3K4me2 histone methylation in mouse asthmatic lung induced by Alt a 1

Thumbnail

D3.115 - Iloprost Attenuates Neutrophilic Airway Inflammation in a Murine Model of Type 2-Low Asthma

Thumbnail

D3.119 - Saving the Caregiver: Humanitarian Access to Dupilumab in a Physician with Severe Non-Allergic T2 Asthma in a Frontline Ukrainian City

Thumbnail

D3.120 - Delivering Severe Asthma Care in the Real World: Insights into Anti-TSLP (Tezepelumab) Use from a Tertiary Allergy and Respiratory Centre

Thumbnail

D3.122 - Real-World Outcomes Of Tezepelumab In Severe Asthma After 12 Months Of Treatment

Thumbnail

D3.123 - The complementary role of impulse oscillometry in prediction of asthma persistance at school age among preschool children with recurrent wheezing

Thumbnail

D3.124 - Effect of psycho-behavioural comorbidities on asthma symptom control scores: implications on asthma remission assessment

Thumbnail

D3.108 - Heterogeneity of Remission Definitions in Asthma and Other Chronic Diseases: Evidence From Two Systematic Reviews

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study